• No results found

18 results with keyword: 'pet mri in breast cancer'

PET/MRI in Breast Cancer

Although who requires whole body PET-based imaging is not standardized, a study of untreated breast cancer patients by Groheux et al showed that PET/CT detects unsuspected metastatic

Protected

N/A

43
0
0
2021
Journal of Nuclear Medicine, published on August 9, 2012 as doi: /jnumed

Example of liver imaging in combined PET/MRI ( 18 F-FDG): patient with breast cancer and liver metastases.. (A)

Protected

N/A

12
0
0
2021
Modular Synthesis of Targeted Molecular Imaging Agents for MRI, PET, and PET-MRI of Cancer

Modular Synthesis of Targeted Molecular Imaging Agents for MRI, PET, and PET-MRI of Cancer.. Kelsea

Protected

N/A

109
0
0
2019
Breast MRI and 18 F FDG PET/CT in the management of breast cancer

Likewise, dedicated breast magnetic resonance imaging (MRI) is gaining a major role in the diagnosis and management of breast cancer patients, demonstrating high sensitivity

Protected

N/A

6
0
0
2021
Simultaneous FAPI PET/MRI Targeting the Fibroblast- Activation Protein for Breast Cancer

n In a retrospective study of 19 women with histologically con- firmed invasive breast cancer, gallium 68 ( 68 Ga)-labeled fibroblast- activation protein inhibitor (FAPI) PET/MRI

Protected

N/A

9
0
0
2022
ECR 2015 Book of Abstracts - E - Authors’ Index

Preoperative axillary lymph node evaluation in breast cancer patients by breast magnetic resonance imaging (MRI): can breast MRI exclude advanced nodal disease.. (SS 202b),

Protected

N/A

49
0
0
2020
PET/CT in Breast Cancer

against systemic staging in patients with stage II disease, our data suggest that PET/CT might be valuable in younger patients with stage IIB and III disease... PET/CT revealed

Protected

N/A

43
0
0
2021
Relevance of breast MRI in determining the size and focality of invasive breast cancer treated by mastectomy: a prospective study

Relevance of breast MRI in determining the size and focality of invasive breast cancer treated by mastectomy a prospective study RESEARCH Open Access Relevance of breast MRI in

Protected

N/A

8
0
0
2020
The value of 18F-fluorodeoxyglucose PET (18F-FDG PET) and MRI spectroscopy in underpinning suspicious breast cancer

Progression of human mammary epithelial cells from normal to malignant phenotype was shown to be associated with an induced overexpression of choline kinase (CK) that catalysed

Protected

N/A

10
0
0
2021
Breast dynamic contrast-enhanced-magnetic resonance imaging and radiomics: State of art

applications of radiomics in breast DCE-MRI: Characterization of breast lesions, prediction of breast cancer histological types, correlation with receptor status,

Protected

N/A

17
0
0
2021
Follow-up of women with breast cancer: comparison between MRI and FDG PET

1 Negative Follow-up (M, US) 12 FP TN Ipsilateral (10 ¥ 8 mm) and Normal ipsi- and contralateral contralateral nodule on (fibroadenoma) findings and mammography, palpable

Protected

N/A

10
0
0
2021
Breast Cancer Analysis in DCE-MRI

In order to understand the techniques, methods and approaches used in this thesis, it is necessary to investigate the context in which they were developed, describing the main

Protected

N/A

213
0
0
2021
Breast MRI: State of the Art

Indications for breast MRI are consolidating; MRI for screening leads to earlier cancer detection in virtually all evaluated populations; in the hands of experienced teams, MRI

Protected

N/A

18
0
0
2021
Application prospective of nanoprobes with MRI and FI dual-modality imaging on breast cancer stem cells in tumor

BC: breast cancer; CSCs: cancer stem cells; BCSCs: breast cancer stem cells; MRI: magnetic resonance imaging; FI: fluorescence imaging; DTPA-Gd: gadopentetatedimeglumine;

Protected

N/A

10
0
0
2020
Potential of asphericity as a novel diagnostic parameter in the evaluation of patients with 68Ga-PSMA-HBED-CC PET-positive prostate cancer lesions

(core needle biopsy); MRI: Magnetic resonance imaging; MTV: Metabolic tumor volume; NSCLC: Non-small cell lung cancer; PC: Prostate cancer; PET: Positron emission tomography;

Protected

N/A

12
0
0
2020
Personalized Breast Screening Service

Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. Tailored

Protected

N/A

5
0
0
2021
Breast inflammation: Indications for MRI and PET-CT

Abstract Breast MRI should not be used for differential diagnosis between inflammatory breast cancer and acute mastitis (AM) prior to treatment.. When mastitis symptoms persist after

Protected

N/A

12
0
0
2021
Genetic Services Policy Project

• Recent American Cancer Society guidelines recommend annual breast MRI screening as an adjunct to mammography in women with a 20 percent or higher risk of breast cancer,

Protected

N/A

9
0
0
2021

Upload more documents and download any material studies right away!